Oragenics, Inc.
- Biotech or pharma, therapeutic R&D
Oragenics is a clinical-stage biotechnology company focused on developing a novel neurosteroid pharmaceutical for neurology, including a drug candidate for treating mild traumatic brain injury (mTBI) aka Concussion.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}